Literature DB >> 18073777

Drug safety in pregnant women and their babies: ignorance not bliss.

C D Chambers1, J E Polifka, J M Friedman.   

Abstract

Although clinical trials address questions regarding drug safety for most segments of the population, pregnant women constitute one special group that is "orphaned" with respect to this issue. The lack of adequate pregnancy safety information for the vast majority of medications, combined with a need to make appropriate treatment decisions and to communicate risk information to a potentially vulnerable population, are some of the most challenging and critical women's health issues.

Entities:  

Mesh:

Year:  2007        PMID: 18073777     DOI: 10.1038/sj.clpt.6100448

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  27 in total

1.  Drug exposure and pregnancy outcome in Mozambique.

Authors:  Esperança Sevene; Azucena Bardají; Alda Mariano; Sónia Machevo; Edgar Ayala; Betuel Sigaúque; John J Aponte; Xavier Carné; Pedro L Alonso; Clara Menendez
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

2.  A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4.

Authors:  Lu Gaohua; Khaled Abduljalil; Masoud Jamei; Trevor N Johnson; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

3.  Clinical research enrolling pregnant women: a workshop summary.

Authors:  Mary A Foulkes; Christine Grady; Catherine Y Spong; Angela Bates; Janine A Clayton
Journal:  J Womens Health (Larchmt)       Date:  2011-08-05       Impact factor: 2.681

4.  Performing Drug Safety Research During Pregnancy and Lactation: Biomedical HIV Prevention Research as a Template.

Authors:  Richard H Beigi; Lisa Noguchi; Gina Brown; Jeanna Piper; D Heather Watts
Journal:  J Womens Health (Larchmt)       Date:  2013-06-29       Impact factor: 2.681

5.  We don't know what we don't study: the case for research on medication effects in pregnancy.

Authors:  Melissa A Parisi; Catherine Y Spong; Anne Zajicek; Alan E Guttmacher
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-07-15       Impact factor: 3.908

6.  Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007.

Authors:  Jennifer N Lind; Sarah C Tinker; Cheryl S Broussard; Jennita Reefhuis; Suzan L Carmichael; Margaret A Honein; Richard S Olney; Samantha E Parker; Martha M Werler
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-04-26       Impact factor: 2.890

7.  Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets.

Authors:  Sofia Frost Widnes; Jan Schjøtt; Geir Egil Eide; Anne Gerd Granas
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

8.  Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial.

Authors:  Walter K Kraft; Eric Gibson; Kevin Dysart; Vidula S Damle; Jennifer L Larusso; Jay S Greenspan; David E Moody; Karol Kaltenbach; Michelle E Ehrlich
Journal:  Pediatrics       Date:  2008-08-11       Impact factor: 7.124

9.  Enrolling pregnant women: issues in clinical research.

Authors:  Mary C Blehar; Catherine Spong; Christine Grady; Sara F Goldkind; Leyla Sahin; Janine A Clayton
Journal:  Womens Health Issues       Date:  2013-01

10.  The perils of protection: vulnerability and women in clinical research.

Authors:  Toby Schonfeld
Journal:  Theor Med Bioeth       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.